Bibliographic Info
Recommendation
Recommended in favor
Strong
Certainty of evidence
High
To prevent relapse, treat P.vivax or P. ovale malaria in children and adults (except pregnant women, infants aged < 6 months, women breastfeeding infants aged < 6 months, women breastfeeding older infants unless they are known not to be glucose-6-phosphate dehydrogenase (G6PD) deficient, and people with G6PD deficiency) with a 14-day course of primaquine in all transmission settings.
Also Featured In
This recommendation also appears in the following guidelines:
Guidelines for the treatment of malaria
WHO guidelines for malaria, 16 February 2021.
WHO guidelines for malaria, 13 July 2021.
WHO guidelines for malaria, 18 February 2022.
WHO guidelines for malaria, 31 March 2022.
WHO guidelines for malaria, 3 June 2022.
WHO recommendations on maternal health: guidelines approved by the WHO Guidelines Review Committee, second edition. Geneva: World Health Organization; 2025
WHO Guidelines for malaria, 14 March 2023